Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma
PaperCitations, authors & open-access status
Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 36 citations, 2020 year and closed oa status.
36
Citations
2020
Year
closed
OA Status